After assessing data from the first 46 adults with refractory nontuberculous mycobacterial lung disease who completed the ...

The vaccine triggers strong immune responses against Mycobacterium tuberculosis and is licensed for commercial development to ...

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung ...

A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...

Initial blood work found hints of an infection, and the doctors initially suspected a bacterial skin infection (cellulitis) ...

MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation ...

Bhubaneswar: The Bhubaneswar-based Indian Institute of Technology (IIT), the Institute of Life Sciences (ILS) along with the ...

Phase 2 trial shows sorfequiline with pretomanid and linezolid may enhance TB treatment efficacy and safety for drug-sensitive patients.

Consistent efforts to prevent Johne’s disease in a high-yielding Wiltshire dairy herd have resulted in cases falling from a ...

Tuberculosis (TB) remains one of the world’s deadliest infectious diseases, claiming 1.23 million lives in 2024 alone, as ...

The number of people diagnosed with tuberculosis worldwide rose again last year, eclipsing 2023's record total.

Over the last few decades, the development of nasal vaccines has been used to deliver treatment for various diseases, ...